[1]
Nagaraju, D. et al. 2026. Piperazine-Pyrrolidone Acyl Hydrazide Hybrids as New Anticancer Agents against Breast Cancer. Asian Journal of Chemistry. 38, 8 (Aug. 2026), 2102–2108. DOI:https://doi.org/10.14233/ajchem.2026.36108.